Literature DB >> 18284844

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

W W Yew, C H Chau, K H Wen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18284844

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  14 in total

1.  Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.

Authors:  Robert S Wallis; Wesley Jakubiec; Vikas Kumar; Gabriella Bedarida; Annette Silvia; Darcy Paige; Tong Zhu; Mark Mitton-Fry; Lynn Ladutko; Sheldon Campbell; Paul F Miller
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

Authors:  Bryan McGee; Reynaldo Dietze; David Jamil Hadad; Lucilia Pereira Dutra Molino; Ethel Leonor Noia Maciel; W Henry Boom; Moises Palaci; John L Johnson; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 3.  Current development and future prospects in chemotherapy of tuberculosis.

Authors:  Eric L Nuermberger; Melvin K Spigelman; Wing Wai Yew
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

4.  Linezolid in the treatment of extensively drug-resistant tuberculosis.

Authors:  L Zhang; Y Pang; X Yu; Y Wang; M Gao; H Huang; Y Zhao
Journal:  Infection       Date:  2014-06-06       Impact factor: 3.553

5.  Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.

Authors:  K N Williams; C K Stover; T Zhu; R Tasneen; S Tyagi; J H Grosset; E Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

Review 6.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

7.  Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.

Authors:  Feng Sun; Qiaoling Ruan; Jiali Wang; Shu Chen; Jialin Jin; Lingyun Shao; Ying Zhang; Wenhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

8.  Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis.

Authors:  Reynaldo Dietze; David Jamil Hadad; Bryan McGee; Lucilia Pereira Dutra Molino; Ethel Leonor Noia Maciel; Charles A Peloquin; Denise F Johnson; Sara M Debanne; Kathleen Eisenach; W Henry Boom; Moises Palaci; John L Johnson
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

9.  Assessment of linezolid efficacy, safety and tolerability in the treatment of tuberculosis: A retrospective case review.

Authors:  Alena Tse-Chang; Dennis Kunimoto; Evelina Der; Rabia Ahmed
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

10.  Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Authors:  D H Vu; M S Bolhuis; R A Koster; B Greijdanus; W C M de Lange; R van Altena; J R B J Brouwers; D R A Uges; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.